Tyler Shultz warns AI boom could repeat Theranos-style deception
In brief
- Theranos whistleblower Tyler Shultz compares AI risks to his former company’s fraudulent practices.
- He warns investors may overlook due diligence amid opaque, unprofitable AI technologies.
- AI firms raise funds at high valuations without transparency, Shultz argues.
Tyler Shultz, the Theranos whistleblower, draws parallels between the AI boom and the fraudulent practices of the disgraced biotech company. He warns investors may repeat past mistakes by overlooking due diligence amid opaque technologies.
Shultz, who exposed Theranos’ faulty blood-testing devices, highlights that many AI firms, often unprofitable, secure massive valuations without transparency. He fears the line between genuine innovation and repackaged models is blurring, enabling large-scale deception.
The documentary *You Can See Everything* reignites debates around Elizabeth Holmes, whose story underscores the dangers of blind trust in technological promises. Shultz warns of a potential repeat in AI, where the lack of tangible proof could mask widespread fraud.
What it changes for you
- HealthHealthcare professionals could be exposed to unreliable AI tools, as seen with Theranos, if investors fail to verify the validity of the technologies.
- Finance & BankingInvestors in AI must strengthen their due diligence processes to avoid funding projects without real technological foundations.
This summary gives you the essentials. The full article, its figures and quotes are on AI News & Artificial Intelligence | TechCrunch.
Read the original articleAI-generated summary of the source, checked by rules. How we write · Report an error